Corporate Ads

$IQST IQSTEL, Inc. (Stock Symbol: IQST) Forecasts $340 Million Revenue for 2025.

$NRXP NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP): Set Up for $300 Million in Milestones on Tiered Double-Digit Royalties

$CYCU Cycurion, Inc. (Stock Symbol: CYCU) Has Delivered $17.8 Million Revenue with +59% y/y Adjusted EBITDA Generating $1.2 Million Net Income for 2024 Full Year.

ZenaTech, Inc. (Stock Symbol: ZENA) $ZENA Latest Focus on High Value Defense and Bathymetry Survey Sonar Markets with Field Testing Underway

NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP) $NRXP Set Up for $300 Million in Milestones on Tiered Double-Digit Royalties

Cadrenal Therapeutics, Inc. (Stock Symbol: CVKD) $CVKD Tecarfarin Anticoagulant Reduces Drug on Drug Interactions Which Pose a Major Issue with Warfarin. Successful Phase III Could Enhance Liquidity and Quickly Attract Large Institutional Investors.

Cybersecurity stocks to watch: $cycu $panw $zs $crwd $chkp $cybr $ftnt $okta $net $ffiv

IQSTEL, Inc. (Stock Symbol: IQSTD) On Track Towards $1 Billion in Revenue by 2027.

$BEAT Clinical Endpoints Successfully Met in Pivotal Study, Plus FDA Clearance for At-Home, High-Fidelity Heart Monitoring System.

$IQSTD Also Signs MOU to Acquire Majority Stake in Fintech Leader GlobeTopper, Plus $1 Million Subsidiary Sale with Stock Dividend to Shareholders. iQSTEL, Inc. (Stock Symbol: IQSTD)